Literature DB >> 12554755

Receptor-interacting protein 140 binds c-Jun and inhibits estradiol-induced activator protein-1 activity by reversing glucocorticoid receptor-interacting protein 1 effect.

Catherine Teyssier1, Karine Belguise, Florence Galtier, Vincent Cavailles, Dany Chalbos.   

Abstract

In the presence of estradiol, estrogen receptor-alpha (ERalpha) increases transcription triggered by activator protein-1 (AP-1). We have previously shown that induction is mediated by the direct interaction between c-Jun and ERalpha, which stabilizes a multiprotein complex containing the coactivator GRIP1 (glucocorticoid receptor interacting protein 1). The effect of receptor-interacting protein 140 (RIP140) in this regulation was assessed in the present study. We report that overexpression of RIP140 inhibits estradiol-induced AP-1-dependent transcription in a dose-dependent manner. Inhibition is not affected by trichostatin A, suggesting that histone deacetylase recruitment is not implicated. RIP140, which binds Jun proteins in pull-down assays and in intact cells, as shown by coimmunoprecipitation analysis and a mammalian one-hybrid system, participates in a multiprotein complex containing c-Jun and ERalpha. Moreover, the negative effect of RIP140 on AP-1-mediated transcription is relieved by GRIP1 overexpression and, conversely, RIP140 inhibits the stimulatory effect of GRIP1. The two cofactors compete for binding to c-Jun and ERalpha both in vitro and in intact cells, and GRIP1 interaction with both ERalpha and c-Jun is required for an efficient competition. These overall results suggest that the ratio between RIP140 and GRIP1 could determine, as proposed for hormone response element-mediated responses, the efficacy of estradiol in stimulating transcription of genes under AP-1 control.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12554755     DOI: 10.1210/me.2002-0324

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  13 in total

1.  The proteins of human chromosome 21.

Authors:  Katheleen Gardiner; Alberto C S Costa
Journal:  Am J Med Genet C Semin Med Genet       Date:  2006-08-15       Impact factor: 3.908

Review 2.  Regulation of hormone signaling by nuclear receptor interacting proteins.

Authors:  Vanessa Duong; Patrick Augereau; Eric Badia; Stéphan Jalaguier; Vincent Cavailles
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

3.  Retinoic acid inhibits endometrial cancer cell growth via multiple genomic mechanisms.

Authors:  You-Hong Cheng; Hiroki Utsunomiya; Mary Ellen Pavone; Ping Yin; Serdar E Bulun
Journal:  J Mol Endocrinol       Date:  2011-03-23       Impact factor: 5.098

Review 4.  Nuclear receptor coactivators: structural and functional biochemistry.

Authors:  Yaroslava A Bulynko; Bert W O'Malley
Journal:  Biochemistry       Date:  2010-12-29       Impact factor: 3.162

5.  Elevated expression of the metabolic regulator receptor-interacting protein 140 results in cardiac hypertrophy and impaired cardiac function.

Authors:  Asmaà Fritah; Jennifer H Steel; Donna Nichol; Nadeene Parker; Sharron Williams; Anthony Price; Leena Strauss; Timothy A Ryder; Margaret A Mobberley; Matti Poutanen; Malcolm Parker; Roger White
Journal:  Cardiovasc Res       Date:  2010-01-18       Impact factor: 10.787

6.  Mineralocorticoid Receptor (MR) trans-Activation of Inflammatory AP-1 Signaling: DEPENDENCE ON DNA SEQUENCE, MR CONFORMATION, AND AP-1 FAMILY MEMBER EXPRESSION.

Authors:  Edward J Dougherty; Jason M Elinoff; Gabriela A Ferreyra; Angela Hou; Rongman Cai; Junfeng Sun; Kevin P Blaine; Shuibang Wang; Robert L Danner
Journal:  J Biol Chem       Date:  2016-09-20       Impact factor: 5.157

7.  Multiple domains of the Receptor-Interacting Protein 140 contribute to transcription inhibition.

Authors:  Audrey Castet; Abdelhay Boulahtouf; Gwennaëlle Versini; Sandrine Bonnet; Patrick Augereau; Françoise Vignon; Saadi Khochbin; Stéphan Jalaguier; Vincent Cavaillès
Journal:  Nucleic Acids Res       Date:  2004-04-01       Impact factor: 16.971

Review 8.  Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways.

Authors:  Stephen Safe; Kyounghyun Kim; Kyoungkim Kim
Journal:  J Mol Endocrinol       Date:  2008-09-04       Impact factor: 5.098

9.  Receptor-interacting protein 140 is a repressor of the androgen receptor activity.

Authors:  Sophie Carascossa; Jérôme Gobinet; Virginie Georget; Annick Lucas; Eric Badia; Audrey Castet; Roger White; Jean-Claude Nicolas; Vincent Cavaillès; Stéphan Jalaguier
Journal:  Mol Endocrinol       Date:  2006-03-09

10.  Estrogen Receptors alpha and beta as determinants of gene expression: influence of ligand, dose, and chromatin binding.

Authors:  Edmund C Chang; Tze Howe Charn; Sung-Hee Park; William G Helferich; Barry Komm; John A Katzenellenbogen; Benita S Katzenellenbogen
Journal:  Mol Endocrinol       Date:  2008-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.